University of Copenhagen

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

University of Copenhagen
Jun 6, 2025, 16:12 | Insight
Foorquan Hashmi: Breakthrough in Cancer Drug Production - A Path to Affordable and Sustainable Chemotherapy
Foorquan Hashmi, MD, Senior Editor at OncoDaily: India Bureau, shared a post on LinkedIn: "Breakthrough…
Mar 28, 2025, 09:34 | Science
Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity
Marco Donia, Professor at University of Copenhagen, shared a post on LinkedIn: "Aspirin releases T…
Mar 15, 2025, 15:11 | Blog
Hadi Mohamad Abu Rasheed: Why Are Women Diagnosed Later Than Men?
Hadi Mohamad Abu Rasheed, Scientific Advisor at the Qatar Cancer Society and is an Adjunct…
Mar 10, 2025, 13:33 | Blog
Marco Donia: Adjuvant Immunotherapy for Melanoma and What’s Next in Europe
Marco Donia, Associate Professor in Clinical Oncology at the University of Copenhagen, shared a post…
Mar 3, 2025, 10:57 | Blog
Marco Donia: RNA splicing generates cancer neoantigens, beyond mutations
Marco Donia, Associate Professor in Clinical Oncology at the University of Copenhagen, shared a post…
Feb 17, 2025, 08:07 | Science
Marco Donia: Personalized Cancer Vaccines in Renal Cell Carcinoma - Phase I Study
Marco Donia, Associate Professor in Clinical Oncology at the University of Copenhagen, shared an article…
Feb 7, 2025, 18:44 | Career
Marco Donia has been appointed Professor of Clinical Oncology at the University of Copenhagen
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Nov 16, 2024, 07:19 | Insight
Updated ESMO Clinical Practice Guideline on Cutaneous Melanoma
Marco Donia, Senior Consultant and Clinician-Scientist and Junior Research Group Leader at University of Copenhagen…
Oct 27, 2024, 14:00 | Blog
The potential Antibody Drug Conjugates in solid tumor immunotherapy with Virginia Metrangolo
Virginia Metrangolo, Postdoctoral Researcher at the University of Copenhagen, reshared a post by The Antibody…
Aug 9, 2024, 06:46 | Blog
Annika Hausmann: Setting up my group on Epithelium-Microbiota Crosstalk at ETH Zurich
Annika Hausmann, EMBO Fellow at University of Copenhagen (UCPH), shared a post on X: ''I…
Jul 19, 2024, 22:20 | Insight
Sox4 promoting the resolution of tissue injury in pancreas regeneration and cancer
Luis Arnes, Associate Professor at University of Copenhagen, shared a post on X about a recent…
Jul 19, 2024, 00:37 | Blog
Experts from around the world discussed ways to improve the experiences and outcomes of people with lung cancer - Lung Cancer Policy Network
Lung Cancer Policy Network shared on LinkedIn: "Last week, experts from around the world joined…
May 25, 2024, 10:05 | Insight
Marco Donia: The Role of PD-L1 Assessment in Dual Checkpoint Inhibition for Melanoma
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: "The…
May 12, 2024, 17:41 | Insight
Marco Donia: Circadian rhythm, tumor infiltration of CD8+ T cells, and cancer immunotherapy
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: “Circadian…
May 2, 2024, 13:23 | Insight
Marco Donia: Welcoming the Era of Gene Editing in Medicine
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: "Autologous…
Apr 20, 2024, 07:47 | Drugs
Paper summary by Marco Donia
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Apr 11, 2024, 15:57 | Insight
Marco Donia: Therapeutic Cancer Vaccines - update in Melanoma
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Dec 24, 2023, 18:05 | Insight
Marco Donia: Adjuvant Anti-PD-1 Immunotherapy for Resected Melanoma: Update December 2023
Marco Donia, Associate Professor at National Center for Cancer Immune Therapy, Denmark, shared on LinkedIn:…
Nov 26, 2023, 17:27 | Insight
Marco Donia: Most combinations in oncology have additive but not synergistic efficacy
Marco Donia, Clinical Research Associate Professor at University of Copenhagen, shared on LinkedIn: "Most combinations…
All: 19 Posts: 1 - 100
Special Coverage